Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Hydrobromide, Phenazocine
2. Narphen
3. Phenazocine
4. Phenbenzorphan
5. Phenethylazocine
1. 1239-04-9
2. Phenazocine Hbr
3. Phenethylazocine Bromide
4. Nih-7519
5. Schembl396395
6. Chembl2107297
7. Dtxsid20872382
8. 1,13-dimethyl-10-(2-phenylethyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;hydrobromide
9. 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-phenethyl-2,6-methano-3-benzazocin-8-olhydrobromide
10. 6,11-dimethyl-3-phenethyl-1,2,3,4,5,6-hexahydro-2,6-methanobenzo[d]azocin-8-ol Hydrobromide
| Molecular Weight | 402.4 g/mol |
|---|---|
| Molecular Formula | C22H28BrNO |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 3 |
| Exact Mass | 401.13543 g/mol |
| Monoisotopic Mass | 401.13543 g/mol |
| Topological Polar Surface Area | 23.5 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 432 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 3 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Narcotics
Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)
Analgesics, Opioid
Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)
ABOUT THIS PAGE
A Narphen manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Narphen, including repackagers and relabelers. The FDA regulates Narphen manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Narphen API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Narphen supplier is an individual or a company that provides Narphen active pharmaceutical ingredient (API) or Narphen finished formulations upon request. The Narphen suppliers may include Narphen API manufacturers, exporters, distributors and traders.
click here to find a list of Narphen suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Narphen DMF (Drug Master File) is a document detailing the whole manufacturing process of Narphen active pharmaceutical ingredient (API) in detail. Different forms of Narphen DMFs exist exist since differing nations have different regulations, such as Narphen USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Narphen DMF submitted to regulatory agencies in the US is known as a USDMF. Narphen USDMF includes data on Narphen's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Narphen USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Narphen suppliers with USDMF on PharmaCompass.
Narphen Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Narphen GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Narphen GMP manufacturer or Narphen GMP API supplier for your needs.
A Narphen CoA (Certificate of Analysis) is a formal document that attests to Narphen's compliance with Narphen specifications and serves as a tool for batch-level quality control.
Narphen CoA mostly includes findings from lab analyses of a specific batch. For each Narphen CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Narphen may be tested according to a variety of international standards, such as European Pharmacopoeia (Narphen EP), Narphen JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Narphen USP).
LOOKING FOR A SUPPLIER?
